Attila Patócs Selected Research

Codon (Codons)

1/2019	Germline BRCA1 Mutation Detected in a Multiple Endocrine Neoplasia Type 2 Case With RET Codon 634 Mutation.
8/2009	Uncommon MEN2A phenotype in a patient with a RET protooncogene exon 10, codon 611 mutation.
6/2002	Occurrence of pheochromocytoma in a MEN2A family with codon 609 mutation of the RET proto-oncogene.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Attila Patócs Research Topics

Disease

41	Neoplasms (Cancer) 02/2022 - 09/2002
12	Adenoma (Adenomas) 02/2022 - 05/2003
10	Pheochromocytoma 03/2021 - 06/2002
8	Pituitary Neoplasms (Pituitary Adenoma) 01/2021 - 08/2009
7	Inflammation (Inflammations) 01/2022 - 01/2013
7	Carcinogenesis 01/2021 - 08/2009
7	Adrenal Cortex Neoplasms (Adrenocortical Cancer) 01/2021 - 08/2009
6	Adrenocortical Carcinoma 02/2022 - 09/2009
6	Paraganglioma (Paragangliomas) 03/2021 - 04/2009
6	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2021 - 01/2004
5	Adrenocortical Adenoma (Disease, Conn's) 05/2019 - 05/2003
5	Cushing Syndrome 02/2013 - 05/2003
4	Multiple Endocrine Neoplasia Type 2a (MEN 2) 01/2019 - 06/2002
4	Congenital Adrenal Hyperplasia (Hyperplasia, Congenital Adrenal) 02/2018 - 11/2006
4	Hypertension (High Blood Pressure) 01/2018 - 01/2006
4	Adrenal incidentaloma 01/2014 - 09/2002
3	Glucocorticoid Receptor Deficiency 01/2018 - 11/2006
3	Hyperparathyroidism 01/2012 - 09/2007
3	Multiple Endocrine Neoplasia Type 1 09/2010 - 11/2006
2	Papillary Thyroid Cancer 01/2021 - 04/2017
2	medullary Thyroid cancer 01/2021 - 01/2012
2	Disease Progression 09/2020 - 01/2015
2	Rheumatoid Arthritis 09/2020 - 10/2019
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 10/2019 - 07/2019
2	Addison Disease (Addison's Disease) 08/2019 - 01/2016
2	Osteoporosis 08/2019 - 02/2013
2	Hyperaldosteronism (Conn Syndrome) 01/2019 - 01/2006
2	Type 2 Diabetes Mellitus (MODY) 06/2014 - 02/2013
2	Multiple Endocrine Neoplasia (Multiple Endocrine Adenomatosis) 10/2012 - 12/2010
2	von Hippel-Lindau Disease (von Hippel Lindau Disease) 12/2010 - 12/2009
2	Hypercalcemia (Milk Alkali Syndrome) 01/2009 - 10/2003
1	Breast Neoplasms (Breast Cancer) 06/2022
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Colonic Neoplasms (Colon Cancer) 01/2022
1	Rectal Neoplasms (Rectal Cancer) 01/2022
1	Perivascular Epithelioid Cell Neoplasms 01/2022
1	Intellectual Disability (Idiocy) 01/2021
1	alpha-Thalassemia 01/2021
1	Primitive Neuroectodermal Tumors (PNET) 09/2020
1	Oxyphilic Adenoma (Oncocytoma) 10/2019
1	Dosage-sensitive sex reversal 08/2019
1	Hyperplasia 01/2019

Drug/Important Bio-Agent (IBA)

29	MicroRNAs (MicroRNA)IBA 02/2022 - 09/2009
14	Biomarkers (Surrogate Marker)IBA 03/2021 - 09/2009
11	Proteins (Proteins, Gene)FDA Link 06/2022 - 11/2006
8	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2018 - 05/2003
7	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 06/2022 - 11/2009
6	GlucocorticoidsIBA 06/2022 - 11/2006
6	Messenger RNA (mRNA)IBA 06/2022 - 09/2009
6	Hormones (Hormone)IBA 08/2019 - 01/2011
5	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 09/2002
5	EnzymesIBA 02/2018 - 04/2009
4	Growth Hormone (Somatotropin)IBA 01/2021 - 12/2006
4	Chromogranin AIBA 09/2020 - 01/2015
4	CatecholaminesIBA 01/2019 - 04/2009
3	Dexamethasone (Maxidex)FDA LinkGeneric 06/2022 - 01/2015
3	Codon (Codons)IBA 01/2019 - 06/2002
3	AldosteroneIBA 01/2019 - 05/2003
3	Parathyroid Hormone (Parathormone)IBA 06/2013 - 10/2003
2	RNA (Ribonucleic Acid)IBA 03/2021 - 02/2021
2	Untranslated RNA (Noncoding RNA)IBA 03/2021 - 02/2020
2	Transcription Factors (Transcription Factor)IBA 08/2019 - 05/2019
2	Circulating MicroRNAIBA 01/2019 - 04/2017
2	Steroid 21-Hydroxylase (21 Hydroxylase)IBA 02/2018 - 09/2002
2	ParaffinIBA 01/2018 - 12/2010
2	Formaldehyde (Formol)FDA Link 01/2018 - 12/2010
2	Phosphotransferases (Kinase)IBA 07/2017 - 10/2010
2	ProlactinIBA 05/2016 - 10/2010
2	Nitric Oxide Synthase (NO Synthase)IBA 02/2016 - 01/2015
2	sapropterin (tetrahydrobiopterin)FDA Link 02/2016 - 01/2015
2	Pharmaceutical PreparationsIBA 01/2016 - 01/2015
2	Freund's AdjuvantIBA 10/2015 - 05/2015
2	Caveolin 1IBA 05/2015 - 01/2013
2	Mitotane (Lysodren)FDA Link 01/2015 - 09/2012
2	SteroidsIBA 12/2014 - 11/2006
2	Adrenocorticotropic Hormone (ACTH)FDA Link 04/2012 - 09/2002
2	Succinate Dehydrogenase (Fumarate Reductase)IBA 01/2012 - 04/2009
2	Biological ProductsIBA 06/2011 - 01/2006
2	OsteocalcinIBA 01/2011 - 01/2011
2	Nuclear Proteins (Protein, Nuclear)IBA 10/2010 - 11/2006
2	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 07/2010 - 08/2009
2	CalciumIBA 04/2009 - 10/2003
2	Calcium-Sensing ReceptorsIBA 04/2009 - 09/2007
1	Estrogen ReceptorsIBA 06/2022
1	Progesterone Receptors (Progesterone Receptor)IBA 06/2022
1	NucleotidesIBA 01/2022
1	Circular RNAIBA 03/2021
1	Proton Pump InhibitorsIBA 09/2020
1	Long Noncoding RNAIBA 02/2020
1	CytosineIBA 01/2020
1	5-hydroxymethylcytosineIBA 01/2020
1	5-Methylcytosine (5 Methylcytosine)IBA 01/2020
1	Decitabine FDA Link 01/2020
1	Prednisolone (Predate)FDA LinkGeneric 08/2019
1	DAX-1 Orphan Nuclear ReceptorIBA 08/2019
1	Anterior Pituitary HormonesIBA 05/2019
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2019

Therapy/Procedure

9	Therapeutics 06/2022 - 08/2009
1	Metastasectomy 01/2022
1	Precision Medicine 03/2021